MedCity News January 9, 2020
The Rochester, Minnesota-based healthcare system and San Mateo, California-based population genomics company plan to launch the study in the next few weeks.
One of the largest healthcare systems in the U.S. and a company involved in genomics plan to launch a study to collect population-level genetic data.
San Mateo, California-based Helix said Thursday that it would work with the Mayo Clinic of Rochester, Minnesota, to sequence 100,000 people in order to build a genomic database. The study, called Tapestry, will use Helix’s Exome+ next-generation sequencing technology product to screen participants’ exomes for genetic variants that increase the risk of disease. In particular, participants will be screened for often unrecognized actionable conditions, including familial hypercholesterolemia, the BRCA1 and BRCA2 genes that...
Today's Sponsors
Today's Sponsor